Stifel Reiterates Buy Rating on Cytokinetics (CYTK)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| CYTOKINETICS (NASDAQ: CYTK) | Delayed: 62.33 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.33 | 52 Week High | $13.18 | |||
| Open | $62.33 | 52 Week Low | $6.00 | |||
| Day High | $62.33 | P/E | N/A | |||
| Day Low | $62.33 | EPS | $-1.24 | |||
| Volume | 1 | |||||
